FOXP2 has been implicated in attention deficit-hyperactivity disorder (Demontis et al., 2019), schizophrenia (Lam et al., 2019), and multisite chronic pain (Johnston et al., 2019). Here, FOXP2 is linked to attention deficit-hyperactivity disorder.